| Primary |
| Liver Transplant |
19.7% |
| Renal Transplant |
18.5% |
| Heart Transplant |
8.0% |
| Metastatic Renal Cell Carcinoma |
7.1% |
| Hypertension |
5.2% |
| Breast Cancer Metastatic |
4.8% |
| Prophylaxis |
4.7% |
| Acute Myeloid Leukaemia |
4.5% |
| Renal Cell Carcinoma |
4.2% |
| Immunosuppression |
3.6% |
| Renal Cancer Metastatic |
3.0% |
| Hepatic Neoplasm Malignant |
2.7% |
| Breast Cancer |
2.7% |
| Diabetes Mellitus |
2.2% |
| Tuberous Sclerosis |
2.1% |
| Gastric Cancer |
1.8% |
| Pancreatic Neuroendocrine Tumour |
1.7% |
| Thyroid Cancer |
1.1% |
| Asthma |
1.1% |
| Off Label Use |
1.1% |
|
| Death |
12.5% |
| Pyrexia |
8.8% |
| Vomiting |
8.8% |
| Neoplasm Malignant |
6.1% |
| Concomitant Disease Progression |
5.7% |
| Respiratory Failure |
5.4% |
| Thrombocytopenia |
5.1% |
| Dyspnoea |
4.7% |
| General Physical Health Deterioration |
4.7% |
| Anaemia |
4.0% |
| Pneumonia |
4.0% |
| Neoplasm Progression |
3.7% |
| Oedema Peripheral |
3.7% |
| Diarrhoea |
3.4% |
| Erysipelas |
3.4% |
| Febrile Neutropenia |
3.4% |
| Pleural Effusion |
3.4% |
| Stomatitis |
3.4% |
| Interstitial Lung Disease |
3.0% |
| Pulmonary Embolism |
3.0% |
|
| Secondary |
| Renal Transplant |
20.4% |
| Drug Use For Unknown Indication |
10.0% |
| Heart Transplant |
9.7% |
| Immunosuppression |
7.0% |
| Product Used For Unknown Indication |
6.7% |
| Liver Transplant |
6.0% |
| Hypertension |
5.6% |
| Transplant Rejection |
5.2% |
| Breast Cancer |
4.0% |
| Metastatic Renal Cell Carcinoma |
3.8% |
| Prophylaxis Against Transplant Rejection |
3.8% |
| Prophylaxis |
3.7% |
| Glioblastoma Multiforme |
2.7% |
| Renal Cell Carcinoma |
2.5% |
| Immunosuppressant Drug Therapy |
1.6% |
| Breast Cancer Metastatic |
1.6% |
| Neuroendocrine Tumour |
1.5% |
| Pancreatic Neuroendocrine Tumour |
1.5% |
| Hepatic Neoplasm Malignant |
1.4% |
| Gastric Cancer |
1.4% |
|
| Transplant Rejection |
12.1% |
| Vomiting |
10.8% |
| Troponin I Increased |
7.3% |
| Pyrexia |
6.7% |
| Thrombocytopenia |
6.3% |
| Interstitial Lung Disease |
5.4% |
| Proteinuria |
4.4% |
| Pulmonary Embolism |
4.4% |
| Renal Failure Acute |
4.1% |
| Rash |
3.8% |
| Renal Impairment |
3.8% |
| Sepsis |
3.8% |
| Thrombotic Microangiopathy |
3.8% |
| Neutropenia |
3.5% |
| Septic Shock |
3.5% |
| Urinary Tract Infection |
3.5% |
| Diarrhoea |
3.2% |
| Febrile Neutropenia |
3.2% |
| Pneumonia |
3.2% |
| Stomatitis |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Renal Transplant |
14.9% |
| Immunosuppression |
12.6% |
| Heart Transplant |
8.9% |
| Hypertension |
5.4% |
| Immunosuppressant Drug Therapy |
4.5% |
| Prophylaxis Against Transplant Rejection |
4.4% |
| Coronary Artery Disease |
4.1% |
| Drug Use For Unknown Indication |
4.0% |
| Prophylaxis |
2.9% |
| Breast Cancer Metastatic |
2.5% |
| Glioblastoma Multiforme |
2.0% |
| Pain |
2.0% |
| Renal Cell Carcinoma |
2.0% |
| Pancreatic Neuroendocrine Tumour |
1.9% |
| Hepatitis C |
1.6% |
| Colorectal Cancer |
1.5% |
| Breast Cancer |
1.3% |
| Dyslipidaemia |
1.3% |
| Heart And Lung Transplant |
1.3% |
|
| Renal Impairment |
14.3% |
| Renal Failure Acute |
8.2% |
| Death |
7.1% |
| Pneumonitis |
5.1% |
| Rash |
5.1% |
| Renal Failure |
5.1% |
| Thrombocytopenia |
5.1% |
| Tubulointerstitial Nephritis |
5.1% |
| Disease Progression |
4.1% |
| Drug Interaction |
4.1% |
| Hepatocellular Carcinoma |
4.1% |
| Hypocalcaemia |
4.1% |
| Osteonecrosis Of Jaw |
4.1% |
| Pancytopenia |
4.1% |
| Renal Atrophy |
4.1% |
| Swelling Face |
4.1% |
| Blood Creatinine Increased |
3.1% |
| Enterovesical Fistula |
3.1% |
| Face Oedema |
3.1% |
| Fatigue |
3.1% |
|
| Interacting |
| Immunosuppression |
22.3% |
| Product Used For Unknown Indication |
16.8% |
| Drug Use For Unknown Indication |
8.4% |
| Pulmonary Tuberculosis |
7.3% |
| Hypertension |
5.6% |
| Infection Prophylaxis |
5.0% |
| Tuberculosis |
5.0% |
| Antifungal Prophylaxis |
3.4% |
| Candida Pneumonia |
3.4% |
| Liver Carcinoma |
3.4% |
| Pneumonia Bacterial |
3.4% |
| Liver Transplant |
2.2% |
| Lung Transplant |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Back Pain |
1.7% |
| Erysipelas |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Pain |
1.7% |
| Renal Transplant |
1.7% |
| Blood Pressure |
1.1% |
|
| Pneumonia |
15.2% |
| Renal Failure Acute |
15.2% |
| Drug Interaction |
12.1% |
| Hepatotoxicity |
9.1% |
| Renal Tubular Atrophy |
9.1% |
| Staphylococcal Infection |
6.1% |
| Subdural Haemorrhage |
6.1% |
| Vomiting |
6.1% |
| Angioedema |
3.0% |
| Enteritis |
3.0% |
| Haemoglobin Decreased |
3.0% |
| Lip Swelling |
3.0% |
| Oedema Peripheral |
3.0% |
| Renal Failure |
3.0% |
| Transaminases Increased |
3.0% |
|
